These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7715623)

  • 1. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer.
    Harvey GK; Toyka KV; Zielasek J; Kiefer R; Simonis C; Hartung HP
    Muscle Nerve; 1995 Apr; 18(4):388-94. PubMed ID: 7715623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block.
    Santoro M; Thomas FP; Fink ME; Lange DJ; Uncini A; Wadia NH; Latov N; Hays AP
    Ann Neurol; 1990 Sep; 28(3):373-7. PubMed ID: 2132741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
    Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
    Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ganglioside antibodies in peripheral neuropathy.
    McCombe PA; Wilson R; Prentice RL
    Clin Exp Neurol; 1992; 29():182-8. PubMed ID: 1343861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants.
    Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP
    Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ; Pestronk A; Bieser K; Ho TW; McKhann GM; Wu HS; Jiang Z
    Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do GM1 antibodies induce demyelination?
    Lange DJ; Trojaborg W
    Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower motor neuron syndrome associated with anti-GM1 antibodies.
    Villa A; Molina H; Sanz OP; Garreto N; Kholer G; Sica RE
    Medicina (B Aires); 1997; 57(3):270-4. PubMed ID: 9640758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
    Pestronk A; Chaudhry V; Feldman EL; Griffin JW; Cornblath DR; Denys EH; Glasberg M; Kuncl RW; Olney RK; Yee WC
    Ann Neurol; 1990 Mar; 27(3):316-26. PubMed ID: 2327739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies.
    Santoro M; Uncini A; Corbo M; Staugaitis SM; Thomas FP; Hays AP; Latov N
    Ann Neurol; 1992 Apr; 31(4):385-90. PubMed ID: 1586139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
    Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
    Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of testing for anti-GM1 antibodies.
    McCombe PA; Wilson R; Prentice RL
    J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
    Irie S; Saito T; Kanazawa N; Ito H; Kowa H
    Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.